Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

Conditions: Diphtheria; Tetanus; Pertussis Interventions: Biological: DTacP (one-dose booster); Biological: DTacP (three-dose primary vaccination); Biological: DT (one-dose booster); Biological: DTaP (one-dose booster); Biological: PENTAXIM (one-dose booster); Biological: DTaP (three-dose primary vaccination); Biological: PENTAXIM (three-dose primary vaccination) Sponsors: Institute of Medical Biology, Chinese Academy of Medical Sciences; Sichuan Center for Disease Control and Prevention Not yet recruiting

https://clinicaltrials.gov/study/NCT06184542

Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials